Emeline Cros‐Perrial

483 total citations
33 papers, 371 citations indexed

About

Emeline Cros‐Perrial is a scholar working on Molecular Biology, Physiology and Organic Chemistry. According to data from OpenAlex, Emeline Cros‐Perrial has authored 33 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 19 papers in Physiology and 7 papers in Organic Chemistry. Recurrent topics in Emeline Cros‐Perrial's work include Adenosine and Purinergic Signaling (19 papers), Biochemical and Molecular Research (10 papers) and Cytomegalovirus and herpesvirus research (6 papers). Emeline Cros‐Perrial is often cited by papers focused on Adenosine and Purinergic Signaling (19 papers), Biochemical and Molecular Research (10 papers) and Cytomegalovirus and herpesvirus research (6 papers). Emeline Cros‐Perrial collaborates with scholars based in France, Italy and Egypt. Emeline Cros‐Perrial's co-authors include Lars Petter Jordheim, Charles Dumontet, Suzanne Peyrottes, Laurent Chaloin, Eva‐Laure Matera, Jack A. Tuszyński, Maria Grazia Tozzi, Khaled Barakat, Rolando Pérez and David S. Wishart and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Journal of Chromatography A.

In The Last Decade

Emeline Cros‐Perrial

30 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emeline Cros‐Perrial France 13 211 145 75 44 43 33 371
Emine Ercikan Abali United States 9 177 0.8× 38 0.3× 56 0.7× 15 0.3× 18 0.4× 23 311
Da Chen China 9 118 0.6× 31 0.2× 78 1.0× 53 1.2× 26 0.6× 13 286
Finn Myhren Netherlands 12 275 1.3× 35 0.2× 124 1.7× 43 1.0× 63 1.5× 17 438
H. N. Jayaram United States 13 363 1.7× 84 0.6× 49 0.7× 103 2.3× 30 0.7× 25 472
Bhaskar Saha India 10 161 0.8× 17 0.1× 54 0.7× 70 1.6× 25 0.6× 16 319
Jadd R. Shelton United States 9 281 1.3× 50 0.3× 59 0.8× 94 2.1× 163 3.8× 13 521
John G. Niedzwicki United States 11 300 1.4× 64 0.4× 98 1.3× 78 1.8× 36 0.8× 12 415
Uffe H. Olesen Denmark 16 230 1.1× 111 0.8× 214 2.9× 183 4.2× 11 0.3× 38 689
Pat Carpenter Canada 7 132 0.6× 232 1.6× 162 2.2× 43 1.0× 11 0.3× 7 408
Doris J. Adamson United States 11 325 1.5× 42 0.3× 82 1.1× 68 1.5× 54 1.3× 20 479

Countries citing papers authored by Emeline Cros‐Perrial

Since Specialization
Citations

This map shows the geographic impact of Emeline Cros‐Perrial's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emeline Cros‐Perrial with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emeline Cros‐Perrial more than expected).

Fields of papers citing papers by Emeline Cros‐Perrial

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emeline Cros‐Perrial. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emeline Cros‐Perrial. The network helps show where Emeline Cros‐Perrial may publish in the future.

Co-authorship network of co-authors of Emeline Cros‐Perrial

This figure shows the co-authorship network connecting the top 25 collaborators of Emeline Cros‐Perrial. A scholar is included among the top collaborators of Emeline Cros‐Perrial based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emeline Cros‐Perrial. Emeline Cros‐Perrial is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cros‐Perrial, Emeline, et al.. (2025). SLX4 and XPF are involved in cell migration and EMT in a cell-specific manner. Biochemical Pharmacology. 236. 116885–116885.
2.
Cros‐Perrial, Emeline & Lars Petter Jordheim. (2025). A phenotypic journey into NT5DC proteins in cancer and other diseases. Experimental Cell Research. 446(1). 114468–114468.
3.
Cros‐Perrial, Emeline, Aurélien Lebrun, Zhan-Guo Gao, et al.. (2024). Third‐Generation CD73 Inhibitors Based on a 4,6‐Disubstituted‐2‐Thiopyridine Scaffold. ChemMedChem. 20(6). e202400662–e202400662.
4.
Guitton, Jérôme, et al.. (2023). A Proposed Methodology to Deal with the Impact of In Vitro Cellular Matrix on the Analytical Performances of a Targeted Metabolomic LC-HRMS Method. International Journal of Molecular Sciences. 24(4). 3770–3770. 1 indexed citations
5.
Rodriguez, Céline, Emeline Cros‐Perrial, Christophe Mathé, et al.. (2023). Second‐Generation CD73 Inhibitors Based on a 4,6‐Biaryl‐2‐thiopyridine Scaffold. ChemMedChem. 18(7). e202200594–e202200594. 9 indexed citations
6.
Elmenoufy, Ahmed H., Francesco Gentile, Michael Weinfeld, et al.. (2021). Enhancing the activity of platinum-based drugs by improved inhibitors of ERCC1–XPF-mediated DNA repair. Cancer Chemotherapy and Pharmacology. 87(2). 259–267. 13 indexed citations
7.
Dumontet, Charles, et al.. (2021). CD73 and cN-II regulate the cellular response to chemotherapeutic and hypoxic stress in lung adenocarcinoma cells. Biochimica et Biophysica Acta (BBA) - General Subjects. 1865(5). 129842–129842. 4 indexed citations
8.
Cros‐Perrial, Emeline, et al.. (2020). Targeting the Nucleotide Metabolism Proteins of the NUDIX Family and SAMHD1 in Cancer. Current Medicinal Chemistry. 28(21). 4088–4116. 2 indexed citations
9.
Cros‐Perrial, Emeline, Tai Van Nguyen, Christophe Mathé, et al.. (2020). 4-Substituted-1,2,3-triazolo nucleotide analogues as CD73 inhibitors, their synthesis, in vitro screening, kinetic and in silico studies. Bioorganic Chemistry. 107. 104577–104577. 14 indexed citations
10.
Machon, Christelle, Kamel Chettab, Jérôme Guitton, et al.. (2020). Enhanced migration of breast and lung cancer cells deficient for cN-II and CD73 via COX-2/PGE2/AKT axis regulation. Cellular Oncology. 44(1). 151–165. 11 indexed citations
11.
Nguyen, Tai Van, Emeline Cros‐Perrial, Christophe Mathé, et al.. (2019). Synthesis of Substituted 5′‐Aminoadenosine Derivatives and Evaluation of Their Inhibitory Potential toward CD73. ChemMedChem. 14(15). 1431–1443. 16 indexed citations
12.
Jordheim, Lars Petter, Kamel Chettab, Emeline Cros‐Perrial, Eva‐Laure Matera, & Charles Dumontet. (2018). Unexpected Growth-Promoting Effect of Oxaliplatin in Excision Repair Cross-Complementation Group 1 Transfected Human Colon Cancer Cells. Pharmacology. 102(3-4). 161–168. 8 indexed citations
13.
14.
Cros‐Perrial, Emeline, Rossana Pesi, Christelle Machon, et al.. (2015). Cell proliferation and drug sensitivity of human glioblastoma cells are altered by the stable modulation of cytosolic 5′-nucleotidase II. The International Journal of Biochemistry & Cell Biology. 65. 222–229. 20 indexed citations
15.
Machon, Christelle, Claire Bordes, Emeline Cros‐Perrial, et al.. (2015). Use of designed experiments for the improvement of pre-analytical workflow for the quantification of intracellular nucleotides in cultured cell lines. Journal of Chromatography A. 1405. 116–125. 2 indexed citations
16.
Chettab, Kamel, Emeline Cros‐Perrial, Maxime Lafond, et al.. (2015). Spatial and Temporal Control of Cavitation Allows High In Vitro Transfection Efficiency in the Absence of Transfection Reagents or Contrast Agents. PLoS ONE. 10(8). e0134247–e0134247. 18 indexed citations
17.
Jordheim, Lars Petter, Emeline Cros‐Perrial, Suzanne Peyrottes, et al.. (2015). Determination of the enzymatic activity of cytosolic 5′-nucleotidase cN-II in cancer cells: development of a simple analytical method and related cell line models. Analytical and Bioanalytical Chemistry. 407(19). 5747–5758. 21 indexed citations
18.
Pesi, Rossana, Laurent Chaloin, S. Allegrini, et al.. (2015). The purine analog fludarabine acts as a cytosolic 5′-nucleotidase II inhibitor. Biochemical Pharmacology. 94(2). 63–68. 21 indexed citations
19.
Jordheim, Lars Petter, Khaled Barakat, Eva‐Laure Matera, et al.. (2013). Small Molecule Inhibitors of ERCC1-XPF Protein-Protein Interaction Synergize Alkylating Agents in Cancer Cells. Molecular Pharmacology. 84(1). 12–24. 72 indexed citations
20.
Jordheim, Lars Petter, Adriana Pleșa, Michel Dréano, et al.. (2010). Sensitivity and gene expression profile of fresh human acute myeloid leukemia cells exposed ex vivo to AS602868. Cancer Chemotherapy and Pharmacology. 68(1). 97–105. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026